Low Dose Factor VIII Prophylaxis in Hemophilia: Indian Perspective
Journal: Haematology International Journal (HIJ) (Vol.5, No. 2)Publication Date: 2021-07-20
Authors : Dutta TK;
Page : 1-4
Keywords : Low Dose Factor VIII Prophylaxis in Hemophilia: Indian Perspective;
Abstract
Important complications of hemophilia are bleeding and joint deformity. Episodic treatment of hemophilia with Factor VIII arrests bleeding but not joint deformity. Thus there is a need to administer Factor VIII prophylactically to prevent bleeding and joint deformity. Apart from high dose prophylaxis practised in developing countries, low dose prophylaxis with 10-15 IU/ kg body weight twice/thrice a week is found to be quite effective in resource limited tropical country like India. Significant reduction in musculo-skeletal, visceral bleeding and joint deformity has been observed from various centres in India. Country wide awareness, including at district level, has happened now in India. Factor VIII is more freely supplied by Govt. agencies now.
Other Latest Articles
- Newer Parameters on Electronic Cell Counter for Diagnosis of Infections
- Prevalence of Transfusion-Transmissible Infections and Associated Risk Factors among Blood Donors in Bamenda, Cameroon
- Genetic Polymorphism of Endothelial Nitric Oxide Synthase in Sickle Cell Disease Patients in South-Eastern Nigeria
- Acute Myeloid Leukemia with BCR-ABL1 Translocation: A Rare Entity
- Some Haematological Parameters of the Elderly in Sokoto, Nigeria
Last modified: 2022-09-12 19:01:53